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ABSTRACT The structure of the Bowman-Birk inhibitor from Vigna unguiculata seeds (BTCI) in complex with b-trypsin was
solved and reﬁned at 1.55 A˚ to a crystallographic Rfactor of 0.154 and Rfree of 0.169, and represents the highest resolution for a
Bowman-Birk inhibitor structure to date. The BTCI-trypsin interface is stabilized by hydrophobic contacts and hydrogen bonds,
involving two waters and a polyethylene glycol molecule. The conformational rigidity of the reactive loop is characteristic of the
speciﬁcity against trypsin, while hydrophobicity and conformational mobility of the antichymotryptic subdomain confer the self-
association tendency, indicated by atomic force microscopy, of BTCI in complex and free form. When BTCI is in binary com-
plexes, no signiﬁcant differences in inhibition constants for producing a ternary complex with trypsin and chymotrypsin were
detected. These results indicate that binary complexes present no conformational change in their reactive site for both enzymes
conﬁrming that these sites are structurally independent. The free chymotrypsin observed in the atomic force microscopy
assays, when the ternary complex is obtained from BTCI-trypsin binary complex and chymotrypsin, could be related more to the
self-association tendency between chymotrypsin molecules and the ﬂexibility of the reactive site for this enzyme than to binding-
related conformational changes.
INTRODUCTION
Serine proteinases have diverse biological functionalities that
might be harmful to other organisms different from those
producing such molecules. In biological systems, they are
controlled by several mechanisms including the inactivation
by proteolytic degradation or by interaction with inhibitors,
which act as pseudo-substrates displaying variable degrees of
afﬁnity to the enzyme’s catalytic sites (1,2).
Natural inhibitors have been classiﬁed into at least 18 dif-
ferent families (3) among which the best studied are the
serine proteinase Bowman-Birk inhibitors (BBIs) and Kunitz
type inhibitors. BBIs are small and cysteine-rich serine pro-
teinase inhibitors with a molecular mass of 6–20 kDa. They
are widespread in monocotyledonous and dicotyledonous
plants (4), particularly in leguminous seeds. The reactive sites
are known to inhibit trypsin and chymotrypsin in monocot-
yledonous plants and elastase in dicotyledonous plants.
The interest in understanding the physiological signiﬁ-
cance of proteinase inhibitors has increased due to their reg-
ulating action in different processes related with proteinases.
They are involved in intracellular protein breakdown, tran-
scription, cell cycle, cell invasion, and apoptosis (5). Plant
proteinase inhibitors have been described as storage proteins
and as protective agents against plant infection and in plant
defense processes (6,7). Soybean proteinase inhibitor has
also been recognized as powerful carcinogenesis suppressor
agents in animal and in vitro transformation systems and
presented no adverse or toxic effects to the pancreas or to
animal growth at doses up to two orders-of-magnitude higher
then the doses being tested in people (8). Therefore, the struc-
tural studies of BBIs may provide novel insights on structural
features and potential anticarcinogenic effects on cellular pro-
cesses and in the gene expression regulation in many cancer
cell lines.
Three-dimensional structures of several BBI in the free
form (9–16) and in complex with trypsin (17–22) have been
reported. However, no crystal structure of a Bowman-Birk
inhibitor in complex with chymotrypsin has been reported,
and the only structural studies on an atomic level of this
complex are by molecular modeling (13,23). However, the
crystallization and preliminary crystallographic information
describing the crystal of BBI in complex with trypsin and
chymotrypsin, without three-dimensional details, was re-
ported before (24). All structures of BBIs are similar and
have a common fold for the reactive site consisting of two
distinct binding subdomains composed by a b-hairpin in an
antiparallel b-sheet stabilized by disulﬁde bonds. The sur-
face loops extended toward the solvent, providing easier
access to the cognate enzyme’s active site (22). The loops are
generally very rigid, reducing the unfavorable decrease in
entropy that accompanies complex formation (2,25). The
change in ﬂexibility of the loops is important to identify the
internal dynamics of the binding to compare the different
molecules and their afﬁnity (26).
The most unusual structural features of BBIs are the ex-
posed hydrophobic patches and absence of a hydrophobic
core (12,20,23). This is in contrast to the hydrophobic interior
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and hydrophilic exterior typically observed in the majority
of globular proteins. The detailed structural analysis of soy-
bean BBI indicate the presence of these exposed hydrophobic
patches, buried charged residues forming an electrically charged
cluster at the interdomain boundary and internal water mol-
ecules. These structural features in the interdomain region
may help stabilize the relative arrangement of the two sub-
domains (12). The internal water molecules were also found
in pea, peanut, and mung bean BBI indicating that they are a
part of the tertiary structures of these inhibitors (10,12,13,18,
19). Hydrophilic bridges and conformational rigidity of sub-
domain 1 in the binding region are characteristic of narrow
speciﬁcity against trypsin whereas increased hydrophobicity
and a signiﬁcant conformational mobility are characteristic of
subdomain 2. The exposed hydrophobic patches predominant
in subdomain 2 seem to be responsible for the self-association
of the inhibitor (12,14,20).
Most of BBIs tend to form homo or hetero-dimers, trimers,
or more complex oligomers (27–29) and some of studies
indicate the pivotal role of charged interactions in the case
of monomer/dimer equilibria (30). The inhibitor from winter
pea seeds was crystallized with a nearly perfect twofold sym-
metric dimmer in the asymmetric unit. Although the reactive
sites of interaction with proteases are located on the surface
of the dimer, it is unlikely that the dimeric form is the func-
tional state of the molecule (13).
The black-eyed pea trypsin/chymotrypsin inhibitor (BTCI)
is a Bowman-Birk type proteinase inhibitor isolated from
Vigna unguiculata seeds presenting two different and inde-
pendent reactive sites for trypsin and chymotrypsin, respec-
tively (31). The binding of trypsin and chymotrypsin to
BTCI was characterized as an endothermic, spontaneous,
and entropically driven process (32,33). This inhibitor is a
stable globular protein (34) with 83 residues and seven
disulﬁde bonds (35). The binary and ternary complexes of
BTCI with trypsin and chymotrypsin have been puriﬁed and
extensively physicochemically characterized on the basis of
hydrodynamic methods (36). Spectroscopic data on solvent
perturbation and surface accessibility (35,37), light scatter-
ing (38), and the molecular homology model indicate an
unusual hydrophobic surface, in contrast to standard proteins
that comprise a hydrophobic core and exposed polar amino
acids (23). Multimeric states of BTCI were identiﬁed from
atomic force microscopy (AFM) analysis. BTCI adopts stable
and well-packed self-assembled states in monomer-dimer-
trimer-hexamer equilibrium with globular-ellipsoidal shapes
(39). The absence of hydrophobic core and the high content of
disulﬁde bonds result in a constrained conformation that may
be responsible for the remarkable stability exhibited by this
inhibitor (34), in agreement with other BBIs (12).
In this article, we present the three-dimensional structure of
BTCI in complex with bovine trypsin determined by molec-
ular replacement methods at 1.55 A˚ resolution and discuss the
binary and ternary complexes features and the self-association
tendency of these proteins by AFM experiments.
METHODS
Puriﬁcation of proteins
BTCI was puriﬁed from V. unguiculata seeds (31). The bovine chymotryp-
sin was purchased from Sigma (St. Louis, MO). The bovine trypsin was
puriﬁed by chromatography on a SP-Sephadex C-25-120 (Pharmacia, Peapack,
NJ) from 23 crystallized trypsin (Sigma). The binary complexes (BTCI-
chymotrypsin and BTCI-trypsin) were obtained by mixing BTCI and en-
zymes 1:1 at the concentration of 5 mM in 100 mM phosphate buffer, pH 7.4
(36) for each protein. All complexes were puriﬁed with size-exclusion
chromatography.
Crystallization, data collection, and processing
Crystallization was achieved using the hanging-drop vapor diffusion method
at 21C. The crystals of BTCI-trypsin complex were grown in a droplet of
2 mL of protein solution at 8 mg/mL in sodium citrate buffer pH 4.0 and
2 mL of reservoir solution containing 0.1 M HEPES-Na buffer pH 7.5, 5%
(v/v) polyethylene glycol (PEG) 400 and 2.0 M ammonium sulfate (40). The
x-ray diffraction datasets were collected at the MX1-D03B beamline of the
Laborato´rio Nacional de Luz Sı´ncrotron (Campinas, Brazil), at l¼ 1.431 A˚,
Df ¼ 1.0 on a mar345 detector system. Crystals were soaked in mother
solution containing 15% glycerol (v/v) as the cryoprotectant before data
collection at 100 K. The diffraction data set was scaled and integrated using
HKL2000 (41). The crystals were from space group P212121 with cell
dimensions a ¼ 60.50, b ¼ 61.11, and c ¼ 79.26 A˚, angles a ¼ b ¼ g ¼
90.00. The ﬁrst crystals diffracted to a resolution of 2.36 A˚ (40), but the best
crystal was produced later, diffracting to 1.55 A˚ resolution.
Molecular replacement
The structure of the complex was solved by molecular replacement using the
crystallographic structure of trypsin in complex with Phaseolus angularis
BBI (17) (PDB code 1TAB) as a search model (40). A partially reﬁned
model from the ﬁrst x-ray dataset at 2.36 A˚ resolution was used to ﬁnd the
molecular replacement solution for the best dataset at 1.55 A˚ resolution.
The set of reﬂections used to calculate the Rfree was kept the same for both
datasets up to 2.36 A˚ resolution and was generated from 2.36 to 1.55 A˚
resolution for the higher resolution dataset. A summary of x-ray data
collection statistics for the best dataset is given in Table 1.
Model building and reﬁnement
The residues of P. angularis inhibitor were replaced by those of BTCI where
the sequences differed using the program O (42). Initial reﬁnement was
performed using CNS (43) against the 2.36 A˚ resolution dataset. Using these
previously reﬁned coordinates against the 1.55 A˚ dataset yielded an initial
Rfactor and Rfree of 0.265 and 0.279, respectively. At this point, the re-
ﬁnement program was changed to REFMAC (44) from the CCP4 (45)
package. Positional reﬁnement was alternated with model rebuilding and
visualization sessions using the graphic modeling package O (42) and Coot
(46). Water molecules were initially added automatically using the program
ARP/wARP (47) and later by inspection of the electron density maps. The
molecules of PEG, sulfate, and acetate were built into their corresponding
electron densities using models from the HICUP server (48). The stereo-
chemistry quality of this model was assessed with the PROCHECK program
(49). The reﬁnement statistics are presented in Table 1.
Structural comparisons and analysis
BTCI structural neighbors search was performed with vector alignment
search tool, VAST (50). The selected BBIs three-dimensional structures
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(9,11,13,14,16,21) (PDB codes: 1PI2, 1BBI, 1PBI, 1MVZ, 1H34, and
1DF9) were superimposed onto the BTCI model using the backbone atoms
of the subdomains containing reactive sites with the visual molecular dy-
namics software (51), and the overall and reactive site’s RMSD were cal-
culated. The ﬂexibility of the reactive site for trypsin and chymotrypsin were
analyzed based on the average B-factor. The protein-protein interface of
BTCI-trypsin complex was analyzed using the BSMPP server (52) and
PyMOL program, Ver. 0.98 (53). The electrostatic potential was generated
using GRASP (54).
Atomic force microscopy (AFM) measurements
of BTCI-proteinases complexes
AFM measurements were carried out following the direct surface adsorp-
tion method usually applied for biomaterials, cells (55), and proteins (39).
Samples of the binary and ternary BTCI-proteinase complexes and the pro-
teinases in monomeric forms were prepared (100 mg/mL) by air-drying a
5 mL drop of stock solutions into a freshly cleaved mica surface for 20 min.
All AFM experiments were carried out in the intermittent-contact mode
operation on a TopoMetrix Explorer TMX 2000 atomic force microscope
(TopoMetrix, Santa Clara, CA). Supertip AFM probes with curvature radius
,20 nm mounted on cantilevers (200 mm) with a typical spring constant
of 0.032 N/m were used. Scanned areas (1 mm/s speed scan) were perfect
squares (1 mm 3 1 mm) to which a weak force (,500 pN) was applied.
Standard topographic intermittent contact and lateral force acquisition
modes were simultaneously obtained. All AFM images contained 500 3
500 data points and the raw data images were processed and analyzed with
the SPMLab 4.0 software (TopoMetrix Explorer) with only background
slopes corrected. The reported lateral dimensions of surface features are the
full width at half-maximum height. For control experiments, the Milli-Q
water was applied onto a mica support and imaged after air-drying (Millipore,
Billerica, MA). Randomly distributed contaminations in control measure-
ments were always ,0.5 nm in height. The accessible surface area and mo-
lecular volume were calculated as previously described for BTCI (39) using
VADAR 1.4 software (56). Statistical and mathematical analyses of data
were performed using ORIGIN 6.0 software.
Inhibitory activity assay of binary complexes
The inhibitory activities of the binary complexes, BTCI-trypsin and BTCI-
chymotrypsin, were assayed by evaluating the chymotrypsin and trypsin
activities using the substrates n-glutaryl-L-phenylalanine-p-nitroanilide (GPNA)
and Na-benzoyl-DL-arginine-p-nitroanilide (BAPNA), respectively (57).
The BAPNA and GPNA were purchased from Sigma. The concentrations
of the proteins used in this assay were determined from measurements of
absorbance on a JASCO V-530 spectrophotometer (JASCO, Tokyo, Japan)
and using the following values: trypsin (Mm ¼ 24 kDa), A1%280;1-cm ¼ 15:9;
chymotrypsin (Mm ¼ 24 kDa), A1%280;1-cm ¼ 20:4; BTCI-trypsin (Mm ¼
25 kDa), A1%280;1-cm ¼ 13:7; and BTCI-chymotrypsin (Mm ¼ 25 kDa),
A1%280;1-cm ¼ 16:8 (58). All components of the assay were diluted in 50 mM
Tris-HCl, CaCl2 20 mM pH 7.6 for chymotrypsin or pH 8.2 for trypsin
residual activity measurements. The binary complexes BTCI-trypsin
and BTCI-chymotrypsin used in these assays were puriﬁed as reported by
Ventura et al. (36) and their concentrations varied at ;106 and 108 M,
respectively. The ternary complex was formed by incubating 250 mL of
enzyme at a ﬁxed initial concentration (28.60 mM for chymotrypsin and
2.57 mM for trypsin) with 250 mL of the binary complex lacking the enzyme
in various concentrations at room temperature for 15 min. After this
incubation, 1250 mL of GPNA at 0.8 mg/mL or BAPNA at 0.064 mg/mL
were added. The reaction was stopped by addition of 250 mL 30% acetic
acid, leading to a ﬁnal volume of 2 mL.
The enzymatic hydrolysis of the substrate was evaluated by recording
the absorbance at 410 nm. The residual activities of the enzymes, in the
presence of the binary complexes, were estimated considering the free
enzyme activity to be 100%. The obtained values are an average of three
independent measurements. Inhibition curves were obtained by plotting
decreasing relative activities of the chymotrypsin and trypsin versus binary
complex concentration. Inhibition constants of the enzyme-inhibitor com-
plexes, Ki, for each inhibitory assay were calculated from ﬁtted inhibition
curves following the procedure described by Morrison (59), using the
GRAFIT program version 3 (Erithacus Software, Horley, Surrey, United
Kingdom).
RESULTS AND DISCUSSION
Overall crystallographic structure of the
BTCI-trypsin complex
Despite extensive physicochemical and structural studies of
serine proteinase inhibitors, no three-dimensional structures
of BBIs in complex with chymotrypsin have been reported.
TABLE 1 X-ray data collection and reﬁnement statistics
Data collection
Space group P212121
Cell parameters (a, b, c) (A˚) 60.50, 61.11, 79.26
Resolution range (A˚) 40.00–1.55 (1.63–1.55)
Wavelength (A˚) 1.431
Oscillation () 1.0
Detector distance (mm) 57
Number of frames 162
I/s(I) before merging 14.9
I/s(I) after merging 30.5 (4.9)
Completeness (%) 99.5 (98.6)
Redundancy 6.3(5.9)
Rsym* 0.060 (0.353)
Number of reﬂections 273,490
Number of unique reﬂections 43,170 (4216)
Reﬁnement statistics
Resolution range (A˚) 30.00–1.55
Number of reﬂections 43111
Rfree 2145
Number of nonhydrogen atoms 2486
Protein 2102
Water 323
Heteroatoms 61
Rfactor
y 0.154
Rfree 0.169
RMS deviations from ideality
Bond lengths (A˚) 0.011
Bond angles (A˚) 1.483
Average temperature factor (A˚2) 20.53
Protein overall (A˚2) 18.12
Solvent molecules (A˚2) 34.61
Heteroatoms (A˚2) 28.38
Ramachandran plot
Most favored regions (%) 87.8
Additional allowed regions (%) 11.8
Generously allowed regions (%) 0.4
Overall G factor 0.1
*Rsym ¼ S jI  ÆIæj / S jIj, where ÆIæ is the average intensity of equivalent
reﬂections.
yRfactor ¼ S kIoj  jFck / jFoj.
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Furthermore, relatively few structures in their free forms
(9–16) or associated with trypsin in binary (17,21) and
ternary complexes (18,20,22) have been reported. The
crystal structure of the BTCI-trypsin complex was solved
by molecular replacement using the crystallographic struc-
ture of trypsin in complex with P. angularis BBI (17) (PDB
code 1TAB) as a search model. The reﬁnement converged to
a ﬁnal working Rcryst and Rfree factors of 0.154 and 0.169,
respectively. This model represents the highest resolution
structure of a BBI molecule available, 1.55 A˚. All data col-
lection, phasing, and reﬁnement statistics are summarized in
Table 1.
The ﬁnal complex model includes residues 17–72 of
BTCI, 16–238 of trypsin, 323 water molecules, four sulfate
ions, two acetate, and three PEG molecules. The quality of
the density did not allow the tracing of two segments of the
BTCI (residues 1–16 and 73–83), which presumably are part
of a ﬂexible regions at the N- and C-terminus of the molecule,
as reported for others BBI deposited at PDB (9,11,13,16).
The model’s stereochemistry quality indicated that 87.8%,
11.8%, and 0.4% of the residues are in most favored, in ad-
ditional and generously allowed regions of the Ramachandran
plot, respectively. No unreasonable geometry for the com-
plex structure was found.
The BTCI structure
The overall shape of the BTCI molecule resembles an elon-
gated cylinder with dimensions of ;42 3 22 3 18 A˚3. The
structure of BTCI folds into two similar compact subdo-
mains, 1 and 2, each with ;30 residues (Fig. 1). Each sub-
domain has three b-strands forming an antiparallel b-sheet.
A striking feature of the BTCI is the presence of 14 cysteine
residues that forms seven disulﬁde bonds. This fold is con-
served in all BBIs and is easily identiﬁable by the cysteine
pattern present in the sequence of these inhibitors as shown
in the alignment in Fig. 1. Interestingly, the unusual buried
cluster of charged side chains located in the intersubdomain
region, previously pointed out in 1BBI (11) and 1MVZ (14),
has been also identiﬁed in BTCI (Asp36, Arg38, and His43)
and in almost all structures presented in Fig. 1 b. In addition,
the conserved Asp63 compose the above charged cluster
making hydrogen bonds mediated by water molecules. BBIs
present another cluster made of highly conserved aromatic
residues (Phe67, Tyr69, and the His43 in BTCI), positioned in
a typical orthogonal geometry (14). This structural feature
has been described, together with the hydrogen-bond network
and the seven disulﬁde bonds, to confer a high stability to this
class of inhibitors (14,60).
Each subdomain of the BTCI contains one reactive site
capable of binding to the active site of the cognate
proteinase. The reactive site is formed in a conserved loop
connecting two strands. The loop between strands 1 and 2
contains Lys26 as the P1 residue that is speciﬁc for trypsin,
while the loop between strands 4 and 5 contains Phe53 as P1,
for chymotrypsin. The distance between the Ca atoms of the
two reactive sites (32.5 A˚) is very similar to that of the BBIs
in free form showing that there is no big changes in the over-
all structure upon binding. This separation allows the inhibition
of two proteinase molecules simultaneously and indepen-
dently (13,15,18,20,22).
The structural similarities among individual three-
dimensional chains of BBIs were computed by the VAST
algorithm (50). The pairwise RMSD between the identiﬁed
structural neighbors and BTCI was calculated for the overall
alignment and just for the antitryptic binding loop. The low
RMSD values indicate that the complete structure (0.5–1.7 A˚)
and especially the antitryptic reactive site of the inhibitors
FIGURE 1 The BTCI structure. (a) Ribbon diagram of
the BTCI structure showing disulﬁde bonds and P1
residues in subdomains 1 and 2 and stabilizing residues
of the intersubdomain region in the BTCI structure. (b)
Sequence alignment of representative BBIs identiﬁed by
their PDB code BTCI (V. unguiculata seeds), 1H34 (lima
bean), 1BBI (soybean), 1PBI (pea seeds), 1MVZ (snail
medic seeds), 1PI2 (tracy bean), and 1DF9 (mung bean).
The residues comprising the reactive loops are enclosed by
boxes. The identical amino acids are represented in black,
while the P1 residues are indicated by *. Subdomains 1 and
2 are indicated by open and shaded boxes underneath the
alignment, respectively. The lines connecting the cysteine
residues represent the disulﬁde bonds.
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(0.06–0.75 A˚) retain identical three-dimensional arrange-
ment. Although BTCI has presented high identity with all
analyzed structures (64.0–78.6%), the 1PBI, 1PI2, 1H34, and
1DF9 (crystallographic structures) have the highest struc-
tural similarity, exhibiting RMSD of 0.5–0.9 A˚, whereas the
1MVZ and 1BBI (nuclear magnetic resonance (NMR) struc-
tures) have the RMSD of 1.4 and 1.7 A˚, respectively. It is
worth noticing the impressive RMSD of 0.06 A˚ for the
antitryptic reactive sites of BTCI and 1H34. These results
strongly indicate that BTCI exhibits the known canonical
conformational typical of BBIs (25) with higher similarity
to the crystallographic structures when compared with NMR
ones.
Cysteine residues and the disulﬁde bonds they form are
conserved and well deﬁned in the electron density maps. The
loops between Cys24-Cys32, located in the subdomain 1, and
Cys51-Cys59, located in the subdomain 2 are the most con-
served regions of BBI structures (Fig. 1). The conforma-
tional differences are in the regions that are not involved in
proteinase recognition (3,15). To analyze the ﬂexibility of
the loop containing the reactive site in the BTCI, a com-
parison is made by plotting the average B-factor for each
residue of the BTCI and some of the inhibitors (Fig. 2). The
BTCI exhibits relatively low average overall B-factors
(20.53 A˚2) when compared with other proteinase inhibitors
(1H34, 1PBI, and 1DF9). The B-factors of the reactive site
for trypsin (12.56 A˚2), in complex state, are much lower than
the reactive site for chymotrypsin (29.07 A˚2), in free state,
indicating that the ﬂexibility of the inhibitor might be
reduced upon complex formation. The low B-factors around
this region are due to the involvement of these residues in
extensive polar contacts with the trypsin molecule, which
stabilizes the conformation of the inhibitor (Table 2).
The complex structure and its interface
In the crystal, BTCI binds to one molecule of trypsin driven
mainly by electrostatic forces with the participation of two
water molecules (Fig. 3). The equivalent Ca atoms of trypsin
on the reﬁned complex have an RMSD of 0.47 A˚ compared
to those of the initial trypsin model (PDB entry 1TAB),
showing that the enzymes’ structures in both complexes
are closely related. Furthermore, trypsin and the b-hairpin
containing the Lys26 reactive site are well superimposed,
whereas differences are present in the Phe53 reactive site
(data not shown).
BTCI binds to trypsin primarily at Lys26, the P1 residue
(Fig. 3, a and b), although many other residues participate in
FIGURE 2 B-factor plot for BBIs crystallographic models indicated by
their PDB code. The average B-factor for all atoms in each residue is plotted
as a function of residue number of BTCI. P1 residues (Lys26 and Phe53) are
indicated, as antitryptic and antichymotriptic reactive site, respectively.
TABLE 2 Polar contacts between BTCI, trypsin, selected
waters, and PEG\3.2 A˚ apart
BTCI Trypsin Waters PEG1
P5 Cys22:O Ser217:OG
Cys22:O W132
Cys22:NH W123
P4 Glu23:OE1 Gln175:OE1
Glu23:OE2 W83
Glu23:OE2 W73
P3 Cys24:NH Gly216:O
Cys24:O Gly216:NH
P1 Lys26:NH Ser214:O
Lys26:NH Ser195:OG
Lys26:O Gly193:NH
Lys26:O Ser195:NH
Lys26:O Ser190:OG
Lys26:NZ Ser190:O
Lys26:NZ Ser190:OG
Lys26:NZ Asp189:OD2
Lys26:NZ W2
Lys26:NZ W3
Gly219:O W3
Asp189:OD1 W3
P19 Ser27:NH Ser195:OG
Ser27:OG W95
P29 Ile28:NH Phe41:O
Ile28:O Lys60:NZ
Ile28:O W322
P39 Pro29:O W95
P49 Pro30:O W88
P59 Gln31:OE1 19:O
Gln31:NE2 W95
Gln31:NE2 W116
W71 19:O
P79 Arg33:NH1 Ser96:O
Arg33:NH2 Asn97:O
Arg33:NH2 13:O
Arg33:NE W103
Gln175:OE1 W103 10:O
W103 7:O
W323 7:O
4:O
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the interface. Table 2 summarizes the polar interactions that
occur between the two proteins, selected waters, and a PEG
molecule. The side chain of Lys26 is clearly shown in the
electron density map and it is in an extended conﬁguration
that perfectly complements the substrate S1 speciﬁcity
pocket of the enzyme (Fig. 3 c). The conformation of this
reactive site is maintained by a hydrogen-bond network
involving P2 and P19 exposing the P1 side chain for primary
interaction with trypsin (12,15,18). The positively charged
amino group at the tip of Lys26 is stabilized mainly by the
negatively charged Asp189 side chain at the trypsin’s S1
pocket mediated by the water molecule W3 (Fig. 3 c).
Another polar contact in the interface includes water mole-
cule, W2, which directly contacts the P1 amino group.
Besides the Lys26-Asp189 salt bridge, this protein-protein
interface is also characterized by a patchy surface with hy-
drophobic and hydrophilic side chains (Fig. 4, a and b).
Secondly most important is the hydrogen-bond network
between BTCI and trypsin involving the residues and waters
listed in Table 2. Weaker hydrophobic interactions, carbon
or sulfur atoms separated by ,4.5 A˚, between the BTCI
(Glu23, Thr25, Ser27, Ile28, and Pro30) and trypsin (Tyr39,
Phe41, Cys42, His57, Leu99, Tyr172, Cys191, Gln192, Ser195,
Val213, Trp215) stabilize the interface. In BTCI, Lys26, Ile28,
Glu23, Arg33, and Thr25, listed in decreasing order of in-
terface ASA, correspond to 70% of ASA of the interface that
is buried upon complexation, calculated according to Jones
and Thornton (52). In the enzyme, the ﬁve residues that
contribute most for the buried area in the enzyme surface are
Glu192, His57, Trp215, Gln175, and Tyr39 and reach a total of
44%. These data support the hydrophobic and hydrophilic
contacts observed and listed previously.
A PEG molecule from the crystallization solution is also
present in the inhibitor-enzyme interface, near the reactive
site. The electron density clearly shows six ethylene-glycol
units (Fig. 4 c). The ﬁrst four ethylene-glycol units of the
PEG are deeply buried within the complex, with the Arg33
side chain from BTCI surrounding and preventing its access
to the solvent. There are many interactions between the
PEG molecule and the proteins. The hydrophilic ones are
presented in Table 2, while the hydrophobic ones are with
the following residues: Glu23, Cys24, Thr25, Glu31, Arg33,
Ser35, Phe60, and Ile64 from BTCI and Thr98, Leu99, Glu175,
and Trp215 from trypsin.
The rigidity of the BBIs has been extensively described
and has led to the assumption that these inhibitors do not
change their structure upon complexation (21,25). In con-
trast, De la Sierra et al. (13) proposed that a mobility of
FIGURE 3 (a) Overall view of the BTCI-trypsin
complex in ribbon representation. Trypsin is shown in
gray ribbon, BTCI in blue ribbon, and Lys (P1), Phe
(P1), and Asp (S1) residues in stick representation. The
reactivity loops of the BTCI are shown in black trace.
The extended Lys26 side chain is clearly going toward
the S1 pocket to interact with Asp189. (b) Electrostatic
potential surface of trypsin showing the negatively
charged (red) S1 pocket with a backbone model of
BTCI (yellow tube) bound (generated with GRASP).
(c) Stereo view of the BTCI-trypsin complex structure
showing simulated annealing omit electron density
map contoured at 5.0 s. Inhibitor’s residue Lys26,
enzyme’s residues Asp189 and Ser190 and two water
molecules were omitted.
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reactive loops 1 and 2, relative to each other, is necessary
for the precise adjustment of the two enzymes to the in-
hibitor. In addition, Catalano et al. (14) found that the lack
of interdomain disulﬁde bond allows for ﬂexibility of the
spatial orientation of the two domains relative to each other.
Koepke et al. (20) has shown by a ternary crystallographic
complex between soybean BBI and two trypsin molecules
that the conformation of side chains can change dramatically
at the reactive loop responsible for chymotrypsin binding.
In this case, the additional binding site for trypsin seemed
to be located in the chymotrypsin reactive domain. Although
it is unclear whether the reactive loop would change if
bound to its speciﬁc target (chymotrypsin), the conforma-
tional changes are possible. This led to the suggestion that
the predominance of hydrophilic contacts (as also shown for
BTCI in Table 2) and the conformational rigidity of the re-
active loop are responsible for the high speciﬁcity for trypsin,
while high hydrophobicity and signiﬁcant conformational
mobility typical of antichymotryptic subdomain confer a
broad inhibition speciﬁcity and the self-association tendency.
Furthermore, at higher inhibitor concentration the reactive
subdomain of soybean BBI is masked from interacting with
trypsin by self-association via their chymotrypsin inhibitor
site. In the case of the BTCI, the conformational changes
could not be ascertained by crystallography since the BTCI-
chymotrypsin complex did not crystallize in any conditions
tested to date. Furthermore, there are no crystallographic struc-
tures of complexes between BBIs and chymotrypsin avail-
able in the PDB. These facts were addressed by additional
investigation regarding the role of the speciﬁc association of
the BTCI in the ternary complex using an AFM approach.
AFM has the innate capability to accurately resolve, at nearly
physiological conditions, the structures and subunit stoichi-
ometries of proteins. It becomes therefore possible to visualize
heterogeneous oligomerization processes leading to more
than one kind of complex.
Oligomerization state of BTCI-proteinases
binary complexes
BTCI incubated with chymotrypsin and trypsin forms binary
and ternary complexes with a ratio of 1:1 and 1:1:1, re-
spectively, and these assemblies were imaged by AFM as
presented in Fig. 5, a and b, and Fig. 6 a. In this study,
oligomerization processes of the above-mentioned binaries
and ternary structures were considered based on volumetric
parameters. According to our previous studies, this strategy
is a much better indicative of the real protein oligomerization
state than linear measurements (39). The calculated volumes
of trypsin, chymotrypsin, and BTCI monomers were 196 4,
20 6 4, and 10 6 5 nm3, respectively. AFM-determined
volumes of BTCI-proteinases complexes were compared with
VADAR volumes for proteins present in a typical molecular
mass calibration mixture based on three-dimensional coor-
dinates and displayed good agreement (Fig. 7). They corre-
late well for most molecular mass ranges and some small
discrepancy could be clearly associated with solvation aspects
used during VADAR algorithm with the Voronoi method.
Molecular volumes and equilibrium constants of the
binary and ternary complexes formation were determined
FIGURE 4 Hydrophobic and hydrophilic contacts in
the interface of BTCI-trypsin complex. (a) Exposed
surface area of trypsin is shown in cyan and its buried
surface area in close contact with BTCI (amino acids in
stick representation) is shown in green (polar residues),
white (hydrophobic residues), and blue and red (posi-
tively and negatively charged residues). The Asp189 (in
red) is seen only partially deeply buried in the S1 cleft
and the reactive site of the BTCI (P1 Lys26) is seen
projected into the S1 cleft. (b) Stereo-view in the same
orientation as in panel a showing speciﬁc interactions
listed in Table 2 generated with PyMOL (53). (c) The
PEG molecule participating in the stabilization of the
complex inside an omit map contoured at 4.2 s. BTCI
and trypsin are colored in light blue and magenta,
respectively. The P1 residue is also shown.
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from a number (n) of particles represented by AFM images
used to characterize the particles subfamily cluster (Table 3).
Fig. 5, c and d, and Fig. 6 b show the molecular volumes for
BTCI-chymotrypsin (n ¼ 210) and BTCI-trypsin (n ¼ 236),
and the ternary complex, chymotrypsin-BTCI-trypsin (n ¼
562), respectively, ﬁtted by Gaussian distributions. For the
BTCI-chymotrypsin complex, three main peaks at 31 6 8
nm3 (n¼ 78), 676 9 nm3 (n¼ 57), and 1266 8 nm3 (n¼ 25)
FIGURE 5 (a) Topograph of the BTCI-chymotrypsin
complex with a full frame of 150 nm2. Full gray-level range
of the topograph corresponds to 3.13 nm. (b) Topograph
of the BTCI-trypsin complex with a full frame of 150 nm2.
Full gray-level range of the topograph corresponds to 3.04
nm. (c) Gaussian ﬁt of the AFM volume histograms for
BTCI-chymotrypsin. The solid lines are Gaussian ﬁts of the
individual multimeric states. Some volume areas were un-
deﬁned by Gaussian ﬁt, indicated by *. P1, P2, and P4
correspond to monomer, dimer, and tetramer of the com-
plex, respectively. (d) Gaussian ﬁt (P1) of the AFM volume
histograms for BTCI-trypsin. The solid line is the Gaussian
ﬁt of the individual monomer.
FIGURE 6 (a) Topograph of the chymotrypsin-BTCI-
trypsin ternary complex with a full frame of 150 nm2. Full
gray-level range of the topograph corresponds to 4.13 nm.
(b) Gaussian ﬁt AFM volume histograms for puriﬁed
chymotrypsin-BTCI-trypsin. (c) Gaussian ﬁt of the AFM
volume histograms for chymotrypsin-BTCI-trypsin ob-
tained by mixing BTCI-chymotrypsin binary complex with
trypsin. The solid lines are Gaussian ﬁts of the individual
multimeric states. P1 and P2 correspond to monomer and an
unidentiﬁed array of the complex, respectively. (d) Gaus-
sian ﬁt of the AFM volume histograms for trypsin-BTCI-
chymotrypsin obtained by mixing the BTCI-trypsin binary
complex with chymotrypsin. The solid lines are Gaussian
ﬁts of the individual multimeric states. P1 and P2 corre-
spond to free a-chymotrypsin and the monomer of the
ternary complex, respectively.
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(Fig. 5 c, Table 3) were obtained after correction for the
experimentally measured particles. These peaks were con-
sistent to the monomer (P1), dimer (P2), and tetramer (P4) of
the binary association, respectively. The smaller particles
(minor peak at 9 6 4 nm3 (n ¼ 34), indicated by (*) in the
Fig. 5 c (inset) corresponds to the molecular volume of the
BTCI monomer, as previously determined by AFM (39).
These results suggest that on the 1:1 molar ratio between
BTCI and chymotrypsin, the presence of a small amount of
dissociated BTCI could be resultant of the proteinase and/or
inhibitor self-association tendencies by forming their speciﬁc
homo multimers. The light-scattering data also support such
self-association tendency of BTCI (38).
For BTCI-trypsin and chymotrypsin-BTCI-trypsin, uni-
formly well-deﬁned line-ﬁtted Gaussian peaks at 306 8 nm3
(n ¼ 156) and at 51 6 18 nm3 (n ¼ 527), respectively, were
observed in the histograms of the volume distribution (Figs.
5 d and 6 b). These results indicate that the BTCI-trypsin and
chymotrypsin-BTCI-trypsin complexes formation is more
favored than homo multimers’ self-association. The self-
association tendency observed for BTCI-chymotrypsin com-
plex displaying several populations of particles (Fig. 5 c)
and uniform hetero complex population for BTCI-trypsin
complex (Fig. 5 d) can help to explain the differences in the
crystallization processes of these complexes. These obser-
vations conﬁrm the importance of AFM to optimize crystal-
lization procedures indicating the circumstances that might
permit crystal growth (61).
BTCI-proteinases ternary complexes features
Considering that in solution, the ternary complex must be
generated by an initial step of binary complex formation, the
ternary moiety was also obtained according to the probable
following schemes of the association: BTCI-chymotrypsin
plus free trypsin or BTCI-trypsin plus free chymotrypsin
assemblies. In AFM experimental approaches, the equilib-
rium between the different visualized forms (Fig. 6, c and d,
respectively) were analyzed and distinct structural features
upon binding were observed. The structures related to the
ternary complex formed from BTCI-chymotrypsin plus free
trypsin association displayed two line-ﬁtted Gaussian peaks
at 496 12 nm3 (n ¼ 347) and at 876 11 nm3 (n ¼ 73) (Fig.
6 c). Despite the presence of an unidentiﬁed species at
87 6 11 nm3, there is no evidence of reminiscent building
assembly of BTCI-chymotrypsin or free trypsin. On the other
hand, the moieties related to the ternary complex formed
from BTCI-trypsin plus free chymotrypsin displayed line-
ﬁtted Gaussian-peak at 18 6 6 nm3 (n ¼ 88) and at 49 6
12 nm3 (n ¼ 267) (Fig. 6 d). In this case, the observed
reminiscent building assemblies (chymotrypsin molecules at
18 6 6 nm3) suggest that a BTCI conformational change
may occur upon binding with trypsin or the self-association
tendency of chymotrypsin prevent the complete conversion
to the ternary form. As previously reported, the ultraviolet
difference spectra arise, in the absorption region of the
aromatic residues, when BTCI interacts with trypsin or
chymotrypsin to form the respective binary complex (62,63).
These spectra reﬂect that the enzyme-inhibitor interaction is
accompanied by changes in the environment of the enzyme-
inhibitor system. The also expected but not visualized
presence of reminiscent BTCI-trypsin molecules may be due
to no well-deﬁned Gaussian peaks between P1 and P2 peaks
(Fig. 6 d).
TABLE 3 AFM-determined Gaussian-ﬁtted molecular
parameters evaluated for proteins and their complexes
Vol. (nm3) Ratio* Freq. (%) Keq
BTCIy 10 6 5 — 22 —
Dimer 22 6 6 2.2 16 0.0340
Trimer 34 6 5 3.4 11 0.0320
Hexamer 69 6 7 6.9 22 0.1740
BTCI-a-chymotrypsin 31 6 8 — 37 0.0149
Dimer 67 6 9 2.2 27 0.0194
Tetramer 126 6 8 4.1 12 0.0164
BTCI-trypsin 30 6 8 — 66 0.0264
Ternary (puriﬁed) 51 6 18 — 93 —
BTCI-chymotrypsin 1 trypsin 49 6 12 — 76 0.0302
Unknown speciesz 87 6 11 1.8 16 —
BTCI-trypsin 1 chymotrypsin 49 6 12 — 68 0.0270
Unknown species§ 18 6 6 — 22 —
Chymotrypsin 20 6 4 — 52 —
Dimer 41 6 4 2.1 24 0.0024
Trimer 63 6 5 3.1 17 0.0008
Tetramer 82 6 3 4.1 4 0.0071
Trypsin 19 6 4 — 65 —
Tetramer 75 6 3 3.9 24 0.0024
*Oligomer/monomer ratio.
yBTCI parameters previously determined (39).
zUnidentiﬁed molecular structure.
§Unidentiﬁed molecular structure with molecular volume related to the
dissociated chymotrypsin.
FIGURE 7 Correlation between the molecular mass and volume of the
molecular marker proteins (a-lactalbumin, soybean trypsin inhibitor, car-
bonic anhydrase, ovalbumin, albumin, and phosphorylase b) obtained by
AFM and VADAR. Good correlation (within error) could be observed for
molecular masses ,66 kDa.
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Proteinases self-association
Although BTCI-proteinases complexes themselves could
explain structural aspects of the protein-protein association,
the following remarkable question concerning the self-
association tendency related to biological function remained
as an argument ﬁeld: which structural attributes contribute to
the presence of dissociated forms from ternary complex
formation based on BTCI-trypsin plus free chymotrypsin, as
shown in Fig. 6 d. Factors such as self-association tendency
between chymotrypsin molecules, net charge balance changes,
or binding-related conformational changes and the ﬂexibil-
ity of the reactive site for chymotrypsin could contribute to
this unexpected feature. These speculative features were rein-
forced by the previous ﬁnding of the conformational changes
in the environment of the enzyme-inhibitor system (62,63)
and by the calculated binding constants for trypsin and chy-
motrypsin to BTCI-proteinase complexes as discussed in the
following section.
To investigate the possible role of the described self-
association of proteinases, molecular volume determinations
from AFM images of the puriﬁed chymotrypsin and trypsin
were analyzed (Fig. 8, a and b). Line-ﬁtted Gaussian peaks
showed in Fig. 8, c and d, reveal the volumetric values
consistent to monomeric forms of chymotrypsin (20 6 4
nm3, n ¼ 277) and trypsin (19 6 4 nm3, n ¼ 273),
respectively, that are in agreement with molecular volumes
calculated by VADAR (Fig. 7). However, the additional
peaks also reveal the proteinases’ self-association tendency.
In the case of chymotrypsin (Fig. 8 c) the observed schemes
of association were consistent to dimers (41 6 4 nm3, n ¼
129), trimers (63 6 5 nm3, n ¼ 91), and tetramers (82 6 3
nm3, n ¼ 22); whereas, in the case of trypsin, only tetramers
(75 6 3 nm3, n ¼ 100) were observed (Fig. 8 d). Smaller
particles, indicated by * in Fig. 8 c, probably correspond to
the molecular volume of dissociated subunits of chymotryp-
sin monomer or autodigestion. It has been well recognized
that several enzymes involved in biochemical pathways
associate to form multienzyme complexes. This feature
still remains as a controversy since some research groups
hypothesize that there is no structural or functional gain upon
self-association and others researchers believe that pro-
teinase self-association tendency leads to some biological
advantage in the enzymatic reaction. Our ﬁndings showed
that close-related enzymes (chymotrypsin and trypsin) have
distinct tendencies of multicomplex formation. It may
represent a speciﬁc and distinct way that allows substrates
(or substrate mimicking, like inhibitors) to efﬁciently access
the active sites. In case of chymotrypsin, it has been recently
recognized that the oligomerization has a crucial role for
determining the afﬁnity and speciﬁcity of inhibitors (64).
They have demonstrated that the binding energy for turkey
ovomucoid third subdomain and chymotrypsin association is
close to the coupled monomer-dimer equilibrium of chymo-
trypsin. In the present AFM study, we have evidence that in
addition to dimers, trimers and tetramers could also contrib-
ute in a minor extent to the ﬁnal binding energetic balance.
FIGURE 8 (a) Topograph of the a-chymotrypsin with
a full frame of 150 nm2. Full gray-level range of the
topograph corresponds to 2.57 nm. (b) Topograph of the
trypsin with a full frame of 150 nm2. Full gray-level range
of the topograph corresponds to 2.42 nm. (c) Gaussian ﬁt
of the AFM volume histograms for chymotrypsin. The solid
lines correspond to the individual multimeric states. Vol-
ume areas undeﬁned by Gaussian ﬁt were indicated by *.
P1, P2, P3, and P4 correspond to monomer, dimer, trimer,
and tetramer of the protein, respectively. (d) Gaussian ﬁt
of the AFM volume histograms for trypsin. The solid lines
are Gaussian ﬁts of the individual multimeric states. Some
volume areas were undeﬁned by Gaussian ﬁt. P1, and P4
correspond to monomer, and tetramer of the protein, re-
spectively.
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Proteinase binding in a ternary complex
In an attempt to rationalize the AFM ﬁndings, we investi-
gated the proteinase-inhibitor binding properties of the
BTCI-trypsin complex with chymotrypsin and of the BTCI-
chymotrypsin complex with trypsin. As has been shown,
BTCI displays ;10-fold more afﬁnity for the trypsin (Ki ¼
23 108 M) than chymotrypsin (Ki¼1.23 107 M) (32,33).
In this study, we found that when BTCI is in the binary forms
with chymotrypsin or trypsin, the afﬁnity of this inhibitor for
producing a ternary complex shows no signiﬁcant differ-
ences. The inhibition constants (Ki) for each binary complex
against trypsin and chymotrypsin, calculated from ﬁtted
inhibition curves (Fig. 9), were 1.36 6 0.16 3 108 M and
1.13 6 0.34 3 107 M, respectively. These results suggest
that when BTCI is in binary complex with trypsin and chy-
motrypsin it presents no conformational change of the spe-
ciﬁc reactive site for both enzymes. This result corroborates
that both reactive sites are structurally independent. Therefore,
the free chymotrypsin observed in the AFM assays (Fig. 6 d),
when the ternary complex is obtained (Fig. 6 d, P2) bymixing
BTCI-trypsin binary complex with chymotrypsin, could be
related more to the self-association tendency between chy-
motrypsin molecules and the ﬂexibility of the reactive site
for chymotrypsin than to binding-related conformational
changes.
As previously demonstrated, the enzyme inhibitor inter-
action is accompanied by changes in the environment of the
aromatic chromophores of the BTCI-proteinase system
(62,63). The oxidation of tryptophyl residues with n-bromo-
succinimide indicated an involvement of such residues in the
interaction of the inhibitor with trypsin or chymotrypsin (63).
The interaction between trypsin and BTCI results in the
burying of the equivalent to approximately one tryptophyl
group. It was assumed that in the formation of the ternary
complex, the burying of tryptophyl, which results from the
interaction of trypsin with BTCI, is counteracted by the op-
posite effect resulting from the interaction with chymotryp-
sin (62). In agreement with this results, the crystallographic
structure of the BTCI-trypsin shows that the only tryptophyl
residue buried in the interface is Trp215 from the enzyme
(Fig. 4 b).
These results show that BBIs present independent reactive
sites and the conformational changes upon binary and ternary
complexes formation are on the interface of the complexes.
Despite the identiﬁed differences in the self-association
features, the relationship between the structure and its bio-
logical implications still remains as an open question,
especially due to the lack of the structures of the BTCI-
chymotrypsin and ternary complex involving BBIs, trypsin,
and chymotrypsin molecules. However, even though BTCI
is a rigid molecule with high disulﬁde bond content, the
structure displacement of the antichymotryptic subdomain
relative to antitryptic subdomain cannot be discarded, as
previously reported for BBI from pea seeds (13). Indeed, as
indicated by the crystal BTCI-trypsin complex, the anti-
chymotryptic subdomain displays higher ﬂexibility and
hydrophobicity with respect to the antitryptic subdomain,
and these properties could be correlated to the self-association
AFM ﬁndings. It is noteworthy that the difference between
the stable BTCI-trypsin complex with low ﬂexibility and the
BTCI-chymotrypsin complex with a ﬂexible reactive site was
also seen in the ternary complex of soybean BBI (20). This is
in agreement with the reported self-association of subdomain
2 of BBIs that has been suggested to protect it from enzyme
attack (11,13,29,30). The chymotrypsin inhibitory subdo-
main in a soybean proteinase inhibitor (11) presents various
crystal contacts between molecules structurally organized in
trimers indicating that the antichymotryptic subdomain is re-
sponsible for this self-association. Indeed, the self-association
involves charged and hydrophobic residues at subdomain
2 indicating that electrostatic and hydrophobic intermolecular
interactions are the driving forces for inhibitors association
FIGURE 9 (a) Inhibitory activities of BTCI-chymotrypsin complex
toward bovine pancreatic trypsin. The inhibition constant, calculated from
the ﬁtted curve, was 1.366 0.163 108 M. (b) Inhibitory activity of BTCI-
trypsin complex toward bovine pancreatic chymotrypsin. The inhibition
constant, calculated from the ﬁtted curve, was 1.13 6 0.34 3 107 M.
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(14,20,30). This self-association, together with the other dis-
cussed structural aspects, accounts for the structural stability
of the BBIs and indicates a functional and relevant aspect of
the self-association process with a possible involvement of
this subdomain in interactions with other enzymes or macro-
molecules.
This study shows that BTCI has a similar structural ar-
rangement to other BBIs as expected. This group of proteins
has three major roles recognized for them: the regulation of
endogenous seed proteinases, the storage of sulfur amino
acids, and the defense against pathogens and insect attack by
an antidigestive effect inhibiting the proteolysis process. The
described self-association tendency of BTCI can relate to its
function in storage since afﬁnity for itself is a requirement for
the molecular packing in the plant seeds. Also, our results
support that the reactive sites of double-headed inhibitors
belonging to the BBIs are structurally independent motifs,
being able to bind and inhibit both enzymes at the same time.
Furthermore, although it seems that the distribution of chy-
motrypsin-like enzymes among insects is similar to that of
trypsin, midgut chymotrypsin-like activity is usually low in
Lepidoptera (65). This agrees with our ﬁndings since the
BTCI interaction with trypsin is stronger than with chymo-
trypsin, leading to the suggestion that proteinases and their
inhibitors could be implicated in a coevolutionary process.
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